Daniel Lasanow
Vorsitzender bei Polypeptide Laboratories France SAS
Vermögen: 256 599 $ am 30.04.2024
Aktive Positionen von Daniel Lasanow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Polypeptide Laboratories France SAS
Polypeptide Laboratories France SAS Chemicals: SpecialtyProcess Industries Part of PolyPeptide Group AG, Polypeptide Laboratories France SAS is a contract manufacturer of organic peptides. The company is based in Strasbourg, France. | Vorsitzender | 10.04.2017 | - |
Karriereverlauf von Daniel Lasanow
Ehemalige bekannte Positionen von Daniel Lasanow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POLYPEPTIDE GROUP AG | Geschäftsführer | 01.01.2016 | 30.11.2022 |
NextPharma Technologies SA (Belgium) | Corporate Officer/Principal | 01.01.2009 | 01.01.2011 |
UCB-Bioproducts SA
UCB-Bioproducts SA Miscellaneous Commercial ServicesCommercial Services UCB-Bioproducts is a Belgian based, international Contract Services Company, focusing on custom peptide and peptidomimetics (for pharmaceutical use) process development, regulatory services and manufacturing services along with strong support to customers' clinical trials. UCB-Bioproducts mission is to create value by supporting pharmaceutical players to bring innovative drugs to the market to improve the lives of people. | Corporate Officer/Principal | - | - |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Daniel Lasanow
Université Catholique de Louvain | Graduate Degree |
Statistik
International
Belgien | 4 |
Vereinigte Staaten | 2 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chairman | 1 |
Chief Operating Officer | 1 |
Sektoral
Process Industries | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POLYPEPTIDE GROUP AG | Health Technology |
Private Unternehmen | 4 |
---|---|
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
NextPharma Technologies SA (Belgium) | |
UCB-Bioproducts SA
UCB-Bioproducts SA Miscellaneous Commercial ServicesCommercial Services UCB-Bioproducts is a Belgian based, international Contract Services Company, focusing on custom peptide and peptidomimetics (for pharmaceutical use) process development, regulatory services and manufacturing services along with strong support to customers' clinical trials. UCB-Bioproducts mission is to create value by supporting pharmaceutical players to bring innovative drugs to the market to improve the lives of people. | Commercial Services |
Polypeptide Laboratories France SAS
Polypeptide Laboratories France SAS Chemicals: SpecialtyProcess Industries Part of PolyPeptide Group AG, Polypeptide Laboratories France SAS is a contract manufacturer of organic peptides. The company is based in Strasbourg, France. | Process Industries |
- Börse
- Insiders
- Daniel Lasanow
- Erfahrung